Walleye Capital LLC Legend Biotech Corp Call Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $2.88 Million - $4.17 Million	72,800 Added 1820.0%	76,800 $3.4 Million
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $165,180 - $209,969	3,000 Added 300.0%	4,000 $224,000
Q4 2023 Feb 14, 2024	SELL	$57.25 - $69.74 $160,300 - $195,272	-2,800 Reduced 73.68%	1,000 $60,000
Q3 2023 Nov 14, 2023	BUY	$63.16 - $76.5 $240,008 - $290,700	3,800 New	3,800 $255,000
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $892,710 - $1.34 Million	23,400 New	23,400 $955,000

212

77.9M

412K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.73B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.